Literature DB >> 2845153

A viral-cellular junction fragment from a human papillomavirus type 16-positive tumor is competent in transformation of NIH 3T3 cells.

J Y Le1, V Defendi.   

Abstract

A 4.4-kilobase DNA fragment (T4.4) from a human tumor (comprising part of the human papillomavirus type 16 E6 promoter; the E6, E7, and part of the E1 open reading frames; and cellular sequences) was found to be competent to fully transform NIH 3T3 cells. This competency resides in the whole hybrid DNA fragment, since the separate viral or cellular DNA sequences were not active. Abundant E6-E7 transcripts were found in the transformed cells. When the cellular fragments were substituted with polyadenylation sequences from polyomavirus or simian virus 40 DNA, little or no restoration of transforming activity was observed. In experiments in which an exogenous reporting gene, that for chloramphenicol acetyltransferase, was used, the possibility was excluded that the cellular flanking sequences act as a traditional enhancer; yet, when the cellular sequences were placed downstream of a chloramphenicol acetyltransferase expression vector (pSV2 CAT), activity of the reference gene was clearly enhanced. These results indicate that DNA containing human papillomavirus type 16 open reading frames E6 and E7 isolated from the genome of a human tumor has transforming potential, that this potential is realized when the viral DNA is joined to cellular sequences, and that the cellular sequences function in a more complex way than by simply providing polyadenylation signals.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845153      PMCID: PMC253887     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Human papillomavirus type 16 related DNA in an anaplastic carcinoma of the lung.

Authors:  A Stremlau; L Gissmann; H Ikenberg; M Stark; P Bannasch; H zur Hausen
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

2.  Transcription from the polyoma late promoter in cells stably transformed by chimeric plasmids.

Authors:  F G Kern; C Basilico
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

3.  5'-Terminal structure and mRNA stability.

Authors:  Y Furuichi; A LaFiandra; A J Shatkin
Journal:  Nature       Date:  1977-03-17       Impact factor: 49.962

4.  Host-specific activation of transcription by tandem repeats from simian virus 40 and Moloney murine sarcoma virus.

Authors:  L A Laimins; G Khoury; C Gorman; B Howard; P Gruss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

5.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

6.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells.

Authors:  E Schwarz; U K Freese; L Gissmann; W Mayer; B Roggenbuck; A Stremlau; H zur Hausen
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

7.  Cloning of monomeric human papillomavirus type 16 DNA integrated within cell DNA from a cervical carcinoma.

Authors:  T Matsukura; T Kanda; A Furuno; H Yoshikawa; T Kawana; K Yoshiike
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.

Authors:  M Dürst; L Gissmann; H Ikenberg; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer.

Authors:  M Boshart; L Gissmann; H Ikenberg; A Kleinheinz; W Scheurlen; H zur Hausen
Journal:  EMBO J       Date:  1984-05       Impact factor: 11.598

View more
  4 in total

1.  Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells.

Authors:  F X Bosch; E Schwarz; P Boukamp; N E Fusenig; D Bartsch; H zur Hausen
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Topography of early HPV 16 transcription in high-grade genital precancers.

Authors:  C P Crum; M Symbula; B E Ward
Journal:  Am J Pathol       Date:  1989-06       Impact factor: 4.307

3.  Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis.

Authors:  S Jeon; P F Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

4.  Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.

Authors:  M von Knebel Doeberitz; C Rittmüller; F Aengeneyndt; P Jansen-Dürr; D Spitkovsky
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.